The new findings underscore the need for universal screening and treatment for the disorder, as well as concerted research to ...

The protective benefit of ART against viral blips was observed among patients who initiated treatment up to 2 years after HIV acquisition.

Otherwise, my greatest fear is that we will return to the dark days of the epidemic, with significant increases in new infections and deaths.

Today, people over 50 make up the second-largest group of South Africa's HIV-positive population. Twenty years ago, they were the smallest proportion. As people age, their chances for developing ...

Researchers at NYU Langone’s Resilience, Intersectional Stigma, and Empowerment Lab explore barriers to pre-exposure prophylaxis.

Withdrawing or reducing aid has immediate and often fatal effects − not only for the countries receiving aid but for people around the globe.

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional ...

Langat pointed to the Kenya Aids Strategic Framework II, a guiding document in the fight against HIV, where Supkem has been a ...

Although US mortality rates from concurrent HIV and viral hepatitis infection have declined since the late 1990s, gender disparities persist.

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...